Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Retz

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Urologie (Heidelberg, Germany)|November 9, 2022
["Surgery only" is not enough: potential of multimodal therapy in urothelial bladder carcinoma]S C Schmid, J Lewerich, M Retz, et al.
Der Urologe. Ausg. A|June 20, 2007
[The latest news on bladder cancer]M Retz, J Lehmann, R Nawroth, et al.
Der Urologe. Ausg. A|October 16, 2013
[Neoadjuvant, adjuvant and palliative chemotherapy of penile cancer]C Protzel, A K Seitz, O W Hakenberg, et al.
Der Urologe. Ausg. A|November 12, 2015
[YB-1-based virotherapy: A new therapeutic intervention for transitional cell carcinoma of the bladder?]P S Holm, M Retz, J E Gschwend, et al.
Urologie (Heidelberg, Germany)|November 30, 2022
[Value of immunotherapy in the perioperative treatment of localized muscle invasive bladder cancer]J Lewerich, S C Schmid, J E Gschwend, et al.
Onkologie|November 8, 2003
[Systemic chemotherapy for transitional cell carcinoma of the urothelium]J Lehmann, M Retz, M Hack, et al.
Der Urologe. Ausg. A|February 8, 2003
[Gemcitabine in advanced bladder cancer]J Lehmann, M Retz, C Lippert, et al.
Deutsches Arzteblatt International|March 24, 2021
The Diagnosis and Treatment of Patients With Bladder CarcinomaMaike de Wit, Margitta M Retz, Claus Rödel, et al.
Der Urologe. Ausg. A|August 9, 2008
[EMMPRIN (CD147). A new key protein during tumor progression in bladder cancer]R Nawroth, R Stöhr, A Hartmann, et al.
Der Urologe. Ausg. A|August 13, 2008
[Muscle-invasive urothelial carcinoma of the bladder. Detection and topography of micrometastases in lymph nodes]M Autenrieth, R Nawroth, S Semmlack, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Urologie (Heidelberg, Germany)|November 9, 2022
["Surgery only" is not enough: potential of multimodal therapy in urothelial bladder carcinoma]S C Schmid, J Lewerich, M Retz, et al.
Der Urologe. Ausg. A|June 20, 2007
[The latest news on bladder cancer]M Retz, J Lehmann, R Nawroth, et al.
Der Urologe. Ausg. A|October 16, 2013
[Neoadjuvant, adjuvant and palliative chemotherapy of penile cancer]C Protzel, A K Seitz, O W Hakenberg, et al.
Der Urologe. Ausg. A|November 12, 2015
[YB-1-based virotherapy: A new therapeutic intervention for transitional cell carcinoma of the bladder?]P S Holm, M Retz, J E Gschwend, et al.
Urologie (Heidelberg, Germany)|November 30, 2022
[Value of immunotherapy in the perioperative treatment of localized muscle invasive bladder cancer]J Lewerich, S C Schmid, J E Gschwend, et al.
Onkologie|November 8, 2003
[Systemic chemotherapy for transitional cell carcinoma of the urothelium]J Lehmann, M Retz, M Hack, et al.
Der Urologe. Ausg. A|February 8, 2003
[Gemcitabine in advanced bladder cancer]J Lehmann, M Retz, C Lippert, et al.
Deutsches Arzteblatt International|March 24, 2021
The Diagnosis and Treatment of Patients With Bladder CarcinomaMaike de Wit, Margitta M Retz, Claus Rödel, et al.
Der Urologe. Ausg. A|August 9, 2008
[EMMPRIN (CD147). A new key protein during tumor progression in bladder cancer]R Nawroth, R Stöhr, A Hartmann, et al.
Der Urologe. Ausg. A|August 13, 2008
[Muscle-invasive urothelial carcinoma of the bladder. Detection and topography of micrometastases in lymph nodes]M Autenrieth, R Nawroth, S Semmlack, et al.
Pageof 9